For much of my work I focus my research on the various posturings and pretensions of the corporate media. My reason for this is that the best way to debunk "official" narratives is to use their own words against them.
Paxlovid has been something of an inflection point for me, because the corporate media is so far behind the curve on this story. The best in-depth explorations of Paxlovid rebound are not being done by corporate media, but right here on Substack, and we should not ignore it. Igor Chudov and Brian Mowrey's "Unglossed" are just a couple of the excellent go-to sources here, as is Modern Discontent. A key subtext of what I write on this topic is to highlight the reality that the best analysis of the phenomenon is not found within the corporate media, and potentially not even within the peer-reviewed journals, but here on Substack.
Alternative media has always had writers with superior analysis and reporting than corporate media, but Paxlovid is one instance where the difference is so wide as to greatly advance the argument that alternative media is the future of journalism--and that future is a lot closer than folks realize.
Very much so.
For much of my work I focus my research on the various posturings and pretensions of the corporate media. My reason for this is that the best way to debunk "official" narratives is to use their own words against them.
Paxlovid has been something of an inflection point for me, because the corporate media is so far behind the curve on this story. The best in-depth explorations of Paxlovid rebound are not being done by corporate media, but right here on Substack, and we should not ignore it. Igor Chudov and Brian Mowrey's "Unglossed" are just a couple of the excellent go-to sources here, as is Modern Discontent. A key subtext of what I write on this topic is to highlight the reality that the best analysis of the phenomenon is not found within the corporate media, and potentially not even within the peer-reviewed journals, but here on Substack.
Alternative media has always had writers with superior analysis and reporting than corporate media, but Paxlovid is one instance where the difference is so wide as to greatly advance the argument that alternative media is the future of journalism--and that future is a lot closer than folks realize.